483 Document: Azurity Pharmaceuticals, Inc., Mar 2, 2023

FDANews 483 Azurity Pharmaceuticals, Inc. Mar 2 2023 top
Robert J. Martin FDA Investigator

On Mar 02, 2023, the FDA inspected Azurity Pharmaceuticals, Inc.'s Wilmington site. Explore the inspectional observations.